A regenerative medicine-focused preclinical-stage company developing novel antibody therapeutics for precise Wnt signaling modulation
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Regenerative Medicine
Lead Product in Development:
ophthalmology, IBD
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
